Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel and Irinotecan in Advanced Esophageal and Gastric Cardia Adenocarcinoma
NCT00004235Phase 2Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Jan 2000
- Primary completion
- Aug 2004
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of docetaxel, irinotecan in esophageal adenocarcinoma (EAC), Gastric cardia adenocarcinoma (GCA), sponsored by Cancer and Leukemia Group B. Started Jan 2000; status: completed.
02
Drugs
docetaxelirinotecan
03
Conditions
esophageal adenocarcinoma (EAC)Gastric cardia adenocarcinoma (GCA)
Beyond the preview
Go deeper on NCT00004235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004235.